Literature DB >> 32291318

Secretion of Acid Sphingomyelinase and Ceramide by Endothelial Cells Contributes to Radiation-Induced Intestinal Toxicity.

Daniela Leonetti1, Hala Estéphan1,2, Natacha Ripoche1, Nolwenn Dubois1,3, Audrey Aguesse4,5, Sébastien Gouard1, Lisa Brossard6, Sophie Chiavassa3, Isabelle Corre1, Claire Pecqueur1, Michel Neunlist6, Elie Hadchity2, Marie-Hélène Gaugler1, Maxime M Mahé6, François Paris7,3.   

Abstract

Ceramide-induced endothelial cell apoptosis boosts intestinal stem cell radiosensitivity. However, the molecular connection between these two cellular compartments has not been clearly elucidated. Here we report that ceramide and its related enzyme acid sphingomyelinase (ASM) are secreted by irradiated endothelial cells and act as bystander factors to enhance the radiotoxicity of intestinal epithelium. Ceramide and the two isoforms of ASM were acutely secreted in the blood serum of wild-type mice after 15 Gy radiation dose, inducing a gastrointestinal syndrome. Interestingly, serum ceramide was not enhanced in irradiated ASMKO mice, which are unable to develop intestinal failure injury. Because ASM/ceramide were secreted by primary endothelial cells, their contribution was studied in intestinal epithelium dysfunction using coculture of primary endothelial cells and intestinal T84 cells. Adding exogenous ASM or ceramide enhanced epithelial cell growth arrest and death. Conversely, blocking their secretion by endothelial cells using genetic, pharmacologic, or immunologic approaches abolished intestinal T84 cell radiosensitivity. Use of enteroid models revealed ASM and ceramide-mediated deleterious mode-of-action: when ceramide reduced the number of intestinal crypt-forming enteroids without affecting their structure, ASM induced a significant decrease of enteroid growth without affecting their number. Identification of specific and different roles for ceramide and ASM secreted by irradiated endothelial cells opens new perspectives in the understanding of intestinal epithelial dysfunction after radiation and defines a new class of potential therapeutic radiomitigators. SIGNIFICANCE: This study identifies secreted ASM and ceramide as paracrine factors enhancing intestinal epithelial dysfunction, revealing a previously unknown class of mediators of radiosensitivity. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32291318     DOI: 10.1158/0008-5472.CAN-19-1527

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Melatonin reduces inflammation in intestinal cells, organoids and intestinal explants.

Authors:  Xiao-Qiang Yuan; Xu-Ming Zhang
Journal:  Inflammopharmacology       Date:  2021-08-24       Impact factor: 4.473

2.  Ligustilide Prevents Radiation Enteritis by Targeting Gch1/BH4/eNOS to Improve Intestinal Ischemia.

Authors:  Tao Yan; Shun Guo; Tian Zhang; Zhimin Zhang; An Liu; Song Zhang; Yuan Xu; Yuhong Qi; Weihe Zhao; Qinhui Wang; Lei Shi; Linna Liu
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 3.  Targeting of BCL-2 Family Members during Anticancer Treatment: A Necessary Compromise between Individual Cell and Ecosystemic Responses?

Authors:  Sophie Barillé-Nion; Steven Lohard; Philippe P Juin
Journal:  Biomolecules       Date:  2020-07-25

4.  Acid sphingomyelinase-dependent autophagic degradation of GPX4 is critical for the execution of ferroptosis.

Authors:  Faisal Thayyullathil; Anees Rahman Cheratta; Ameer Alakkal; Karthikeyan Subburayan; Siraj Pallichankandy; Yusuf A Hannun; Sehamuddin Galadari
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.